Strategy Note /

Zepp Health boosts R&D, goes global to minimize reliance on Xiaomi

  • Most of Zepp Health's income is generated from Xiaomi-branded products

  • The company continues to excel in wearable devices and healthcare, showing a strong growth momentum

  • Inversely, the firm still faces pressure from shareholders, a tilted revenue structure and a small market share

Yangni Liu
9 May 2021
Published byEqualOcean


Tellimer | Start Following

Start following your markets today

Follow your key analysts, markets and more so they appear here in your Watchlist - allowing you to keep an eye on the latest updates.